Novel three-drug regimen used to manage life-threatening developments.
In April 2021, a 42-year-old man reached out to Brian Hill, MD, PhD, for a second opinion after being diagnosed with hairy cell leukemia following a bone marrow biopsy at a healthcare facility in northwest Ohio.
“At the time of diagnosis, he was getting easily fatigued and couldn’t exercise,” explains Dr. Hill, Director of the Lymphoid Malignancies Program at Cleveland Clinic’s Taussig Cancer Institute. “He was experiencing a slow-moving progression of symptoms.”
Standard front-line therapy for hairy cell lymphoma –an indolent B-cell lymphoproliferative disease – is the chemotherapy medication cladribine. Dr. Hill recommended the patient begin the drug, typically administered daily for five days or via a continuous pump for seven days, but the situation quickly pivoted.
“When I met the patient for a virtual second opinion, I recommended he get vaccinated against SARS-CoV-2 before beginning treatment,” says Dr. Hill. “Within two weeks, however, he was hospitalized with COVID-19 pneumonia.”
Severe COVID-19 sends patient to ICU
The patient was admitted to his local hospital with fever and shortness of breath. He tested positive for COVID-19, and within a few days, his breathing became more labored. He was transferred to Cleveland Clinic’s main campus.
“His critical illness was exacerbated by neutropenia from his leukemia,” says Dr. Hill. “Once he was admitted to our ICU, he rapidly deteriorated.” Within a few days, the patient was intubated and put on mechanical ventilation. His oxygenation levels were so poor that he was placed in the prone position and underwent pharmacologic paralysis.”
Unfortunately, the patient’s severe COVID had severely compromised his immune system. “The only way to improve his neutrophil and white blood cell counts was to get the cancer cells out of the bone marrow,” says Dr. Hill. However, the oncology team quickly realized that the standard chemotherapy approach for hairy cell leukemia could prove detrimental.
“He would unlikely survive short-term worsening of his neutropenia caused by the administration of traditional chemotherapy with cladribine,” explains Dr. Hill.
Second-line treatment given through NG tube
After discussions with other oncologists and the patient’s critical care team, including pulmonology specialists, Dr. Hill began to administer vemurafenib, an FDA-approved tablet medication for treating melanoma that targets mutations in the BRAF gene.
Approximately 90% of hairy cell leukemia cases also have this same BRAF mutation, says Dr. Hill. Although vemurafenib is not as effective as cladribine for hairy cell leukemia, the drug has been proven to be an effective second-line treatment.
Twice a day for more than two weeks, caregivers crushed a 960-mg tablet of vemurafenib and administered it to the patient through a nasogastric tube. He also was treated with remdesivir for COVID-19.
Gradually, the patient’s neutrophil count recovered, his breathing improved and his fever abated. He was weaned off high levels of oxygen.
“His COVID finally turned the corner,” says Dr. Hill. “I give most of the credit to our medical ICU nurses, pharmacists and physicians whose great work kept him going through all this.”
Complications, more treatment and remission
During his time in the hospital, the patient suffered numerous complications, including bacteremia, ventilator-associated pneumonia. He also lost some function in his left hand from neurologic compression of his brachial plexus.
After two months in the medical ICU, the patient was transferred to a medical-surgical unit in mid-June and was later discharged from the hospital July 1. His treatment journey for hairy cell leukemia continued throughout.
“While vemurafenib is a good drug, it wasn’t good enough in his case,” says Dr. Hill. “He stopped making progress while in the hospital, so we gave him a 70% dose of cladribine.” Once discharged, the patient received a standard dosage of the monoclonal antibody medication rituximab, which was necessary due to ongoing cytopenias.
“It was a balancing act to provide enough treatment against the hairy cell leukemia, but not so much to set him back in terms of infectious complications,” explains Dr. Hill.
A year after his hairy cell leukemia diagnosis, the patient is in remission. His only residual medical deficit is impaired inflection of his left wrist, for which he is undergoing physical therapy. The patient is back at home with his family, including his wife and three children. He hopes to return to work within the next few months.
“For patients like this one with rare diseases who have atypical treatment courses, it’s important to think outside the box to get the best outcomes. Cleveland Clinic excels at that,” says Dr. Hill. “In this case, we could not wait for the patient to get better from COVID to treat the cancer. We had to address both at once.”
News
X Marks the Spot: AI’s Treasure Maps Lead to Early Disease Detection
Medical diagnostics expert, doctor’s assistant, and cartographer are all fair titles for an artificial intelligence model developed by researchers at the Beckman Institute for Advanced Science and Technology. Their new model accurately identifies tumors [...]
Scientists Discover Method To Identify Alzheimer’s Disease Before It Progresses to Dementia
Researchers at Aarhus University have discovered a method to identify Alzheimer’s disease before it progresses to dementia, potentially opening up new avenues for treatment. A groundbreaking study could pave the way for early detection [...]
Startling Discovery: COVID-19 Virus Can Stay in the Body More Than a Year After Infection
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential [...]
New bioengineered protein design shows promise in fighting COVID-19
In the wake of the COVID-19 pandemic, scientists have been racing to develop effective treatments and preventatives against the virus. A recent scientific breakthrough has emerged from the work of researchers aiming to combat [...]
Sugar-coated gold nanoparticles can quickly eliminate bacterial infections, no antibiotics required
If left to their own devices, bacteria on our teeth or wounded skin can encase themselves in a slimy scaffolding, turning into what is called biofilm. These bacteria wreak havoc on our tissue and, [...]
Liquid Lightning: Nanotechnology Unlocks New Energy
EPFL researchers have discovered that nanoscale devices harnessing the hydroelectric effect can harvest electricity from the evaporation of fluids with higher ion concentrations than purified water, revealing a vast untapped energy potential. Evaporation is a natural [...]
Unmasking the Illusion: AI-Generated Faces Challenge Perceptions
Research shows survey participants duped by AI-generated images nearly 40 percent of the time. If you recently had trouble figuring out if an image of a person is real or generated through artificial intelligence [...]
New Discovery Reveals How Cells Defend Themselves During Stressful Situations
Stress granules play a crucial role in the stress response, arising from the aggregation of non-translating mRNAs and proteins. Although significant knowledge exists about stress granules, the mechanisms behind their mRNA localization remain partially [...]
Scientists use a new type of nanoparticle that can both deliver vaccines and act as an adjuvant
Many vaccines, including vaccines for hepatitis B and whooping cough, consist of fragments of viral or bacterial proteins. These vaccines often include other molecules called adjuvants, which help to boost the immune system's response [...]
Not Science Fiction: How Optical Neural Networks Are Revolutionizing AI
A novel architecture for optical neural networks utilizes wavefront shaping to precisely manipulate the travel of ultrashort pulses through multimode fibers, enabling nonlinear optical computation. Present-day artificial intelligence systems rely on billions of adjustable [...]
Turning skin cells into limb cells sets the stage for regenerative therapy
In a collaborative study, researchers from Kyushu University and Harvard Medical School have identified proteins that can turn or “reprogram” fibroblasts — the most commonly found cells in skin and connective tissue — into [...]
AI reveals prostate cancer is not just one disease
Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer, which could revolutionise how the disease is diagnosed and treated in the future. A Cancer Research UK-funded study, published in Cell Genomics, has revealed [...]
New Study Finds That Persistent COVID-19 Infections Are Surprisingly Common
Recent research conducted by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published in the journal Nature. [...]
Innovative nanosheet method revolutionizes brain imaging for multi-scale and long-term studies
The human brain has billions of neurons. Working together, they enable higher-order brain functions such as cognition and complex behaviors. To study these higher-order brain functions, it is important to understand how neural activity [...]
Scientists Have Discovered a Potential Universal Antivenom
Scientists at Scripps Research identified antibodies that protect against a host of lethal snake venoms. Scripps Research scientists have developed an antibody that can block the effects of lethal toxins in the venoms of [...]
Scientists discover the human brain is even more powerful than we thought
The human brain could be far more powerful than we ever imagined, scientists have discovered. Researchers have identified cell messaging which have never been uncovered before, which suggests our brains are capable of more than previously realised. It’s [...]